Photo illustration: Axios Visuals. Photo: Courtesy of Breyer Capital
Physician-scientist and drug developer Dr. Bret Bostwick has joined Breyer Capital as venture advisor, the firm exclusively tells Axios Pro.
Why it matters: Bostwick's appointment is part of Breyer's push to deepen its biotech investing as founders and fund managers reported a notoriously difficult fundraising environment.